Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-02-23

FDA Approved: HALOPERIDOL — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)

View source ↗

Summary

The FDA approved a supplemental application for haloperidol from PAI Holdings (PAI Pharma) under ANDA073037, marking an additional approval action for this prod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL (HALOPERIDOL LACTATE)

Snippet

SUPPL AP for HALOPERIDOL (HALOPERIDOL)